z-logo
open-access-imgOpen Access
Combined effects of the proteasome inhibitor bortezomib and Hsp70 inhibitors on the B16F10 melanoma cell line
Author(s) -
Azmi Yerlikaya
Publication year - 2010
Publication title -
molecular medicine reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.727
H-Index - 56
eISSN - 1791-3004
pISSN - 1791-2997
DOI - 10.3892/mmr_000000262
Subject(s) - bortezomib , proteasome inhibitor , mg132 , quercetin , apoptosis , cell cycle , pharmacology , proteasome , chemistry , cancer research , biology , immunology , biochemistry , multiple myeloma , antioxidant

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom